Development of High Signal Intensity within the Globus Pallidus and Dentate Nucleus following Multiple Administrations of Gadobenate Dimeglumine

• Published in: American journal of neuroradiology : AJNR 2018-03, Vol.39 (3), p.415-420
• Main Authors: Bolles, G M, Yazdani, M, Stalcup, S T, Creeden, S G, Collins, H R, Nietert, P J, Roberts, D R
• Format: Article
• Language: English
• Subjects: Adult; Adult Brain; Aged; Cerebellar Nuclei - diagnostic imaging; Cerebellar Nuclei - drug effects; Cerebellum; Contrast agents; Contrast Media - pharmacology; Correlation; Dentate nucleus; Female; Gadolinium; Globus pallidus; Globus Pallidus - diagnostic imaging; Globus Pallidus - drug effects; Humans; Image contrast; Magnetic resonance imaging; Magnetic Resonance Imaging - methods; Male; Meglumine - analogs & derivatives; Meglumine - pharmacology; Middle Aged; Nuclei; Organometallic Compounds - pharmacology; Patient Safety; Patients; Retrospective Studies; Statistical analysis; Thalamus
• ISSN: 0195-6108; 1936-959X
• DOI: 10.3174/ajnr.A5510

Previous studies have evaluated various gadolinium based contrast agents and their association with gadolinium retention, however, there is a discrepancy in the literature concerning the linear agent gadobenate dimeglumine. Our aim was to determine whether an association exists between the administration of gadobenate dimeglumine and the development of intrinsic T1-weighted signal in the dentate nucleus and globus pallidus. In this single-center, retrospective study, the signal intensity of the globus pallidus, dentate nucleus, thalamus, and middle cerebellar peduncle was measured on unenhanced T1-weighted images in 29 adult patients who had undergone multiple contrast MRIs using exclusively gadobenate dimeglumine (mean, 10.1 ± 3.23 doses; range, 6-18 doses). Two neuroradiologists, blinded to the number of prior gadolinium-based contrast agent administrations, separately placed ROIs within the globi pallidi, thalami, dentate nuclei, and middle cerebellar peduncles on the last MR imaging examinations. The correlations between the globus pallidus:thalamus and the dentate nucleus:middle cerebellar peduncle signal intensity ratios with the number of gadolinium-based contrast agent administrations and cumulative dose were tested with either 1-tailed Pearson or Spearman correlations. A priori, < .05 was considered statistically significant. Both the globus pallidus:thalamus and dentate nucleus:middle cerebellar peduncle ratios showed significant correlation with the number of gadolinium-based contrast agent administrations ( = 0.39, = .017, and = 0.58, = .001, respectively). Additionally, the globus pallidus:thalamus and dentate nucleus:middle cerebellar peduncle ratios showed significant correlation with the cumulative dose of gadobenate dimeglumine ( = 0.48, = .004, and = 0.43, = .009, respectively). Dentate nucleus hyperintensity was qualitatively present on the last MR imaging in 79.3%-86.2% of patients and in all patients who had received >10 doses. At high cumulative doses (commonly experienced by patients, for example, with neoplastic disease), gadobenate dimeglumine is associated with an increase in the globus pallidus:thalamus and dentate nucleus:middle cerebellar peduncles signal intensity ratios.